Machine learning-based risk model incorporating tumor immune and stromal contexture predicts cancer prognosis and immunotherapy efficacy.
He LN, Li H, Du W, Fu S, Luo L, Chen T, Zhang X, Chen C, Jiang Y, Wang Y, Wang Y, Yu H, Zhou Y, Lin Z, Zhao Y, Huang Y, Zhao H, Fang W, Yang Y, Zhang L, Hong S.
He LN, et al. Among authors: du w.
iScience. 2023 Jun 7;26(7):107058. doi: 10.1016/j.isci.2023.107058. eCollection 2023 Jul 21.
iScience. 2023.
PMID: 37416452
Free PMC article.